TickerFactsScreenerDevelopers

Skye Bioscience, Inc. (SKYE) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: $4.1K2013: -$120.4K2014: -$2.73M2015: -$4.32M2016: -$4.47M2017: -$3.86M2018: -$4.69M2019: -$6.63M2020: -$6.29M2021: -$7.85M2022: -$18.31M2023: -$34.74M2024: -$30.19M2025: -$58.16M-$58.16M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$58.16M-92.6%
2024-$30.19M+13.1%
2023-$34.74M-89.7%
2022-$18.31M-133.3%
2021-$7.85M-24.8%
2020-$6.29M+5.2%
2019-$6.63M-41.3%
2018-$4.69M-21.6%
2017-$3.86M+13.7%
2016-$4.47M-3.6%
2015-$4.32M-58.0%
2014-$2.73M-2168.8%
2013-$120.4K-3024.5%
2012$4.1K—